CBCT perfusion collaboration targets stroke angio suite
Siemens Healthineers and Cercare Medical are pairing Syngo DynaCT Multiphase with Neurosuite to support perfusion imaging during acute stroke interventions.
Siemens Healthineers and Cercare Medical have announced a global collaboration focused on cone-beam CT perfusion for acute stroke care. The companies said the agreement is intended to support perfusion-guided stroke treatment in the angiography suite.
The joint approach combines Cercare Medical Neurosuite with Siemens Healthineers’ Syngo DynaCT Multiphase. Cercare described Neurosuite as a vendor-neutral imaging software portfolio for automated perfusion analysis across CT, MRI, and cone-beam CT.
Syngo DynaCT Multiphase is a 3D acquisition protocol that can generate up to 10 cone-beam CT angiography phases, according to the announcement. Siemens Healthineers’ product page also describes the protocol as visualizing cerebral collateral vessels across up to 10 time points within 60 seconds.
The combined workflow is designed to provide perfusion and metabolic imaging directly in the angiography suite. The companies said this could reduce the need to move acute stroke patients from the angio room to another imaging modality during intervention.
Supported use cases include tissue viability assessment during and after thrombectomy. The announcement also cited detection of distal occlusions, microvascular disturbances, and the no-reflow phenomenon.
Cercare said its cone-beam CT perfusion solution includes automated CT perfusion maps and automated delineation of infarct core and hypoperfused volumes. Listed map outputs include CBF, CBV, MTT, Tmax, MaxIP, and TTP.
The scientific work behind the collaboration has involved Johannes Kaesmacher, MD, at Inselspital, Bern University Hospital in Switzerland, according to the announcement. Additional projects are underway at 3 other hospitals.
Companies:Siemens Healthineers, Cercare Medical
Siemens Healthineers coverage
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section
Pathology support broadens MedDream viewer scope
Version 8.9.0 is scheduled for June 2026 through aycan and will add support for pathology workflows and saving reconstructed MPR viewports as new study series.
DOSIsoft unit gives PLANET a theranostics focus
DOSIsoft Theranostics will operate within the DOSIsoft group, with its own partnerships and investment strategy centered on PLANET software.
Vault-ready proton system headed to Tam Anh
Mevion said the S250-FIT installation would be Vietnam’s first proton therapy system, with operation expected as early as late 2027 at Tam Anh’s Phu My Hung facility.
I-MED sale gives Jardines 215-clinic radiology network
Jardine Matheson will acquire 100% of I-MED Radiology Network in a deal valued at A$3.4B, including I-MED’s minority stake in Harrison.ai.
Expected Russell addition puts Hyperfine in small-cap benchmarks
FTSE Russell’s preliminary June reconstitution list includes Hyperfine, with index changes set to take effect after U.S. markets close on June 26.
Curium approach puts Lantheus deal value near $7B
Lantheus is weighing a potential sale after an approach from Curium Pharma, while company filings show recent Pylarify pressure and pending PET regulatory milestones.
GE HealthCare to distribute NordicNeuroLab fMRI tools
The agreement covers nordicMEDiVA, nordicAktiva, selected MRI hardware, and patient comfort products across authorized global markets.
Niowave Lansing site to scale Ac-225 supply by 2028
The Lansing, MI, site will house superconducting linear accelerators and radiochemistry systems to support scalable actinium-225 production, with completion expected in 2028.
30-year GE-UW tie expands into CT and theranostics research
The collaboration will focus on CT and molecular imaging technologies for cardiology, oncology, and theranostics workflows at UW Medicine Radiology facilities in Seattle.
Recall issues and isotope shortages weigh on Radnostix Q1 revenue
The radioisotope-focused company reported $2.38M in Q1 revenue, citing recall impacts, isotope shortages, and Cobalt-60 hot cell downtime.
Ephemeral to build AI data platform for Plus CNS oncology programs
The companies will develop an AI platform to integrate therapeutic, diagnostic, and bioinformatics data across Plus Therapeutics’ CNS oncology programs.
Fujifilm balloon-free EBUS scope targets pulmonary setup time
The EB-710US Ultrasound Bronchoscope is designed for pulmonary procedures and will be demonstrated at the American Thoracic Society Conference.